Singular Genomics Systems (OMIC) Projected to Post Earnings on Monday

Singular Genomics Systems (NASDAQ:OMIC) is expected to be posting its quarterly earnings results after the market closes on Monday, March 17th. Analysts expect Singular Genomics Systems to post earnings of ($7.85) per share and revenue of $1.77 million for the quarter.

Singular Genomics Systems Stock Performance

Shares of OMIC opened at $20.01 on Monday. The firm has a 50-day moving average of $19.85 and a 200-day moving average of $17.40. Singular Genomics Systems has a one year low of $5.34 and a one year high of $23.41. The company has a market cap of $50.83 million, a PE ratio of -0.57 and a beta of 1.83. The company has a debt-to-equity ratio of 0.04, a current ratio of 7.37 and a quick ratio of 6.67.

About Singular Genomics Systems

Singular Genomics Systems, Inc, a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue.